Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community.
Daneng LiSpencer ChengAndrea Wilson WoodsAllyson LuongSarah SchiltzRuoding TanZeena Huang ChiPublished in: Journal of hepatocellular carcinoma (2024)
Asian Americans and Pacific Islanders have an increased risk of developing liver cancer and higher risk of death compared to non-Hispanic White individuals. The role of individual-level risk factors, social determinants of health, and barriers navigating health systems present unique challenges in obtaining liver cancer care for these patients. Additionally, the Asian American and Pacific Islander population is a heterogenous group originating from several different countries and speaking various languages, and they are often underrepresented in cancer clinical trial populations. This article describes the challenges faced by Asian American and Pacific Islander patients with liver cancer from the clinician, research, and patient advocacy perspectives and proposes targeted solutions to reduce healthcare disparities in this group.
Keyphrases
- healthcare
- clinical trial
- risk factors
- end stage renal disease
- mental health
- chronic kidney disease
- ejection fraction
- newly diagnosed
- affordable care act
- health information
- prognostic factors
- peritoneal dialysis
- papillary thyroid
- case report
- randomized controlled trial
- cancer therapy
- patient reported outcomes
- squamous cell
- open label
- african american
- phase ii
- genetic diversity
- health promotion